People: Atara Biotherapeutics Inc (ATRA.OQ)
24 May 2019
Dr. Isaac E. Ciechanover, M.D. is the Chairman of the Board, President and Chief Executive Officer of the Company. He served as our President and Chief Executive Officer and a member of the Board since our founding in August 2012. From April 2010 to November 2012, Dr. Ciechanover was a partner at Kleiner Perkins Caufield & Byers, a venture capital firm, where he primarily focused on life sciences investing. From 2004 to March 2010, he served in various capacities at Celgene Corporation, a biopharmaceutical company, most recently as Executive Director for Business Development. Dr. Ciechanover has also held business development and venture capital roles at pharmaceutical companies Amylin Pharmaceuticals and Pfizer and venture capital firm Pequot Ventures. Dr. Ciechanover received a B.A. from Stanford University, an M.Phil. in Epidemiology from Cambridge University, an M.D. from Weill Cornell Medical College and an M.B.A. from Harvard Business School.
|Total Annual Compensation, USD||882,883|
|Restricted Stock Award, USD||2,483,250|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||689|
|Fiscal Year Total, USD||3,366,820|